The Patient Protection and Affordable Care Act and questions surrounding its impact is giving tax advisors and preparers a new role as health care advisors.

The majority of organizations only progressed beyond a compliance focus for diversity and inclusion within the last five years.

A gap in U.S. patent law has kept cheap copies of Novartis AGs heart drug Diovan off the market for 18 months, costing consumers and insurers as much as $900 million in potential savings.